clinical research

New Delhi: Swiss pharma major Novartis is sharpening its strategy in India as a net-innovator in core therapy areas including cardiovascular, oncology and immunology, after selling its stake in its listed arm earlier this year.Notably, India is increasingly contributing to almost every molecule commercialized globally by Novartis, and is moving up the value chain with…